###begin article-title 0
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 43 51 <span type="species:ncbi:9606">Patients</span>
TAP1 and TAP2 Gene Polymorphisms in Korean Patients with Allergic Rhinitis
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*Equally contributed.
###end p 1
###begin p 2
###xml 400 404 400 404 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 409 413 409 413 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 500 504 500 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 553 557 553 557 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 724 728 724 728 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 926 927 926 927 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 1038 1042 1038 1042 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 1114 1118 1114 1118 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 465 473 <span type="species:ncbi:9606">patients</span>
###xml 890 898 <span type="species:ncbi:9606">patients</span>
###xml 1089 1097 <span type="species:ncbi:9606">patients</span>
Antigen peptides are actively transported across the endoplasmic reticulum by the transporters associated with antigen presentation (TAP). TAP genes polymorphism could influence the selection process that determines which antigen peptides play a role in the pathogenesis of allergic rhinitis. The aim of this study was to investigate the association of TAP genes polymorphism with allergic rhinitis. TAP1 and TAP2 genotyping were performed on 110 allergic rhinitis patients and 107 healthy controls. TAP1 polymorphic residues at codons 333 and 637, and TAP2 polymorphic residues at codons 379, 565, 651, and 665 were analyzed by the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR). Analysis of TAP1 gene polymorphism demonstrated decreased frequencies of Ile/Val genotype at codon 333, Asp/Gly genotype at codon 637, and haplotype A and B in allergic rhinitis patients when compared to controls (p<0.05). However, there was no significant difference in the genotype, phenotype, or allele frequencies at four TAP2 codons between controls and allergic rhinitis patients. In conclusion, TAP1 gene polymorphism may be an important factor contributing to the genetic susceptibility in the development of allergic rhinitis in the Korean population.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 426 427 426 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 428 429 428 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
Allergic rhinitis (AR) is an immunologic nasal response, primarily mediated by immunoglobulin E (IgE). It is considered as a heterogenous state, determined by genetic and environmental interactions. Previous studies have shown the relationships between allergies and polymorphisms in many candidate genes such as IgE, transporters associated with antigen processing (TAP), T cell receptors, and cytokines and their receptors (1-5).
###end p 4
###begin p 5
###xml 42 43 42 43 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 74 75 74 75 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 205 206 205 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
The inhalent antigens are presented to CD4+ T cell by MHC class II in AR (6). However, it was suggested that exogenous antigens can be channeled into the endogenous pathway (MHC class I) by TAP molecules (7). Therefore, it would be very interesting to determine the other possible antigenic presentation pathway, mediated by TAP in AR.
###end p 5
###begin p 6
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 9 13 9 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 317 318 314 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 320 321 317 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 471 472 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
TAP1 and TAP2 genes encode heterodimeric molecules involved in endogenous antigen processing. Antigen peptides are degraded from cytosolic proteins, assembled with MHC class I heavy chain and beta2-microglobulin in the endoplasmic reticulum, and actively transported across the endoplasmic reticulum membrane by TAP (8, 9). It is possible that TAP gene polymorphisms can influence the antigen peptide selection and transport process and alter immune response regulation (2).
###end p 6
###begin p 7
###xml 324 326 324 326 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 328 330 328 330 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 472 473 472 473 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 525 529 525 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 606 608 606 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 642 646 642 646 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
The TAP gene is considered to be one of the candidates for disease susceptibility gene or one of the additional genes conferring susceptibility. Polymorphisms of the TAP gene have been investigated in several HLA-associated diseases such as atopic dermatitis, asthma, rheumatoid arthritis, and systemic lupus erythematosus (10, 11). There have been few studies on the relationship between AR and TAP genes polymorphism, and it still remained controversial. Ismail et al. (2) reported evidence of a strong association between TAP1 polymorphism and atopy in a Tunisian population. However, Tacheuchi et al. (12) reported no association between TAP1 gene polymorphism and AR in a Japanese population.
###end p 7
###begin p 8
###xml 156 160 156 160 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 165 169 165 169 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 75 83 <span type="species:ncbi:9606">patients</span>
Until now, there has been no study on the TAP genes polymorphism in Korean patients with AR. Therefore, we designed a case-control study to investigate the TAP1 and TAP2 polymorphisms and their association with AR in a Korean population.
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Subjects
###end title 10
###begin p 11
###xml 46 54 <span type="species:ncbi:9606">patients</span>
###xml 191 199 <span type="species:ncbi:9606">patients</span>
###xml 860 868 <span type="species:ncbi:9606">patients</span>
One hundred and ten consecutive and unrelated patients with AR were included in this study. They consisted of 40 females and 70 males, ranging in age from 5 to 72 yr old (mean, 24.1 yr). All patients had nasal symptoms such as watery rhinorrhea, sneezing, itching and/or nasal obstruction, and positive skin prick tests (Allergopharma(R), Hamburg, Germany) for one or more inhalant allergens including house dust mites. There was no co-morbid condition such as allergic asthma or atopic dermatitis. The control group consisted of 107 healthy subjects with no personal or family history of allergic diseases, cancers or genetic diseases. There were 40 females and 67 males ranging from 7-65 yr old (mean, 26.2 yr). All control subjects were negative for all nasal symptoms and skin prick tests. Prior to the experiment, informed consents were obtained from all patients and controls.
###end p 11
###begin title 12
DNA extraction
###end title 12
###begin p 13
Heparinized peripheral venous blood (about 10 mL) was drawn from each individual and stored at -70℃ before being used in the experiment. Genomic DNA was extracted from leukocytes in the collected blood with the Wizardtrade mark Genomic DNA purification kit (Promega, Madison, WI, U.S.A.).
###end p 13
###begin title 14
ARMS-PCR
###end title 14
###begin p 15
###xml 46 50 46 50 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 88 92 88 92 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 134 138 134 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 138 141 138 141 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 170 174 166 170 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 174 177 170 173 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">637</sup>
###xml 207 211 199 203 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 211 214 203 206 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">379</sup>
###xml 235 239 223 227 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 239 242 227 230 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">565</sup>
###xml 263 267 247 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 267 270 251 254 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">651</sup>
###xml 294 298 274 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 298 301 278 281 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">665</sup>
###xml 322 324 298 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 327 331 303 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 336 340 312 316 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 492 494 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 545 552 521 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 703 707 679 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 707 710 683 686 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 712 716 688 692 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 716 719 692 695 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">637</sup>
###xml 721 725 697 701 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 725 728 701 704 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">379</sup>
###xml 730 734 706 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 734 737 710 713 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">565</sup>
###xml 742 746 718 722 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 746 749 722 725 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">665</sup>
###xml 802 804 778 780 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 811 815 787 791 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 815 818 791 794 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">651</sup>
###xml 873 875 849 851 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
Polymorphic residues at codons 333 and 637 in TAP1, and codons 379, 565, 651 and 665 in TAP2 were analyzed. The dimorphic sites were: TAP1333 (A-->G, Ile-->Val, exon 4), TAP1637 (A-->G, Asp-->Gly, exon 10), TAP2379 (G-->A, Val-->Ile), TAP2565 (G-->A, Ala-->Thr), TAP2651 (C-->T, Arg-->Cys) and TAP2665 (A-->G, Thr-->Ala) (13). TAP1 and TAP2 polymorphism analyses were performed by the amplification refractory mutation system-polymerase chain reaction (ARMS-PCR), described by Newton et al. (14). Four primers were used for each dimorphic site (Table 1). Two of these were complementary to one of the dimorphic sites, while the other two allele-nonspecific primers were used as an internal control. The TAP1333, TAP1637, TAP2379, TAP2565 and TAP2665 primers were designed as described by Powis et al. (15). The TAP2651 primers were designed as described by Jackson et al. (16).
###end p 15
###begin p 16
###xml 160 163 <span type="species:ncbi:9685">Cat</span>
Genomic DNA samples (1 microL) were amplified in a 20 microL reaction mixture containing 1 microL each of all four oligonucleotide primers, 2 microL dNTPs mix (Cat. No. BIO-39029, London, U.K.), 1 microL DNA template, and 13 microL of distilled water. A thermal cycler (GeneAmp PCR system 2400, Perkin Elmer, MA, U.S.A.) was used with the following specifications: 94℃ for 6 min; 35 cycles of 94℃ for 1 min, 62℃ for 1 min and 72℃ for 1 min; there was a final 72℃ incubation for 7 min. The reaction products were separated on a 2% agarose gel stained with ethidium bromide.
###end p 16
###begin title 17
Determination of genotypes and haplotypes
###end title 17
###begin p 18
###xml 18 22 18 22 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 22 25 22 25 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 194 200 194 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Fig. 1</xref>
###xml 221 225 221 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 225 228 225 228 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">637</sup>
###xml 401 405 401 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
Genotyping of the TAP1333 was done as follows: Ile/Val if 241, 351 and 533 bp bands were visible, Ile/Ile if 241 and 533 bp bands were visible, and Val/Val if 351 and 533 bp bands were visible (Fig. 1). Genotyping of the TAP1637 was done as follows: Asp/Gly if 180, 307 and 429 bp bands were visible, Asp/Asp if 307 and 429 bp bands were visible, and Gly/Gly if 180 and 429 bp bands were visible. The TAP2 genotypes were also classified using the same methods.
###end p 18
###begin p 19
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 130 134 130 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 248 252 248 252 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 257 261 257 261 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 314 316 314 316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 338 340 338 340 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 343 350 343 350 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
Four possible TAP1 haplotypes (A-D) were determined by a combination of the dimorphic sites at codons 333 and 637. Eight possible TAP2 haplotypes (A-H) were determined by combination of four dimorphic sites at codons 379, 565, 651 and 665. We used TAP1 and TAP2 haplotype nomenclature as proposed by Powis et al. (15) and Jackson et al. (16) (Table 2).
###end p 19
###begin title 20
Statistical analysis
###end title 20
###begin p 21
###xml 136 140 136 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 145 149 145 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 333 334 333 334 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
All statistical analyses were performed with SPSS 10.0 (Chicago, IL, U.S.A.). A chi-square test was used to compare the distribution of TAP1 and TAP2 genotypes between control and AR groups. Odds ratios (OR) with a 95% confidence interval (CI) were calculated using the Mantel-Haenzel chisquare test. Differences were significant if p<0.05.
###end p 21
###begin title 22
RESULTS
###end title 22
###begin title 23
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
TAP1 polymorphisms and allergic rhinitis
###end title 23
###begin p 24
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 77 84 77 84 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 473 474 473 474 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 404 412 <span type="species:ncbi:9606">patients</span>
Three TAP1 genotypes (Ile/Ile, Ile/Val and Val/Val) were found at codon 333 (Table 3). The Ile/Val genotype was significantly decreased in the AR group when compared to Ile/Ile (OR=0.32, 95% CI=0.17-0.60, p=0.001). The Val phenotype was significantly decreased in the AR group when compared to the Ile phenotype (OR=0.52, 95% CI=0.30-0.92, p=0.016). The Val allele was also significantly decreased in AR patients when compared to the Ile allele (OR=0.48, 95% CI=0.28-0.81, p=0.003).
###end p 24
###begin p 25
###xml 6 10 6 10 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 76 83 76 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T3">Table 3</xref>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 326 327 326 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 384 388 384 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 388 391 388 391 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">637</sup>
###xml 220 228 <span type="species:ncbi:9606">patients</span>
Three TAP1 genotypes (Asp/Asp, Asp/Gly and Gly/Gly) were seen at codon 637 (Table 3). The Asp/Gly genotype was significantly decreased in the AR group when compared to Asp/Asp (OR=0.43, 95% CI=0.24-0.80, p=0.011). In AR patients, the Gly allele was significantly decreased when compared to the Asp (OR=0.62, 95% CI=0.38-1.01, p=0.04). However, there was no difference between the two TAP1637 phenotypes, Asp and Gly.
###end p 25
###begin p 26
###xml 14 18 14 18 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 62 69 62 69 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T4">Table 4</xref>
###xml 154 155 154 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
###xml 171 172 171 172 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">p</italic>
Four possible TAP1 haplotypes (A-D) were found in this study (Table 4). The C and D haplotypes were significantly less than A in the AR group (phenotype, p=0.006; allele, p=0.0002). By combining the four haplotypes, the following seven genotypes were found: AA, AB, AC, AD, BC, BD, and DD. The AB (OR=0.31), AC (OR=0.08), and AD (OR=0.13) genotypes were significantly decreased in the AR group when compared with the AA genotype.
###end p 26
###begin title 27
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
TAP2 polymorphisms and allergic rhinitis
###end title 27
###begin p 28
###xml 90 94 90 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 162 169 162 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T5">Table 5</xref>
###xml 202 206 202 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 283 286 283 286 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">379</sup>
###xml 290 293 290 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">565</sup>
###xml 297 300 297 300 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">651</sup>
###xml 304 307 304 307 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">665</sup>
###xml 340 342 340 342 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 393 396 393 396 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">379</sup>
###xml 400 403 400 403 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">565</sup>
###xml 407 410 407 410 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">651</sup>
###xml 414 417 414 417 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">665</sup>
###xml 490 497 490 497 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 523 527 523 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 668 675 668 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T6">Table 6</xref>
###xml 439 445 <span type="species:ncbi:9606">person</span>
There was no significant difference in the genotype, phenotype, and allele frequencies of TAP2 at codons 379, 565, 651 and 665 between the AR and control groups (Table 5). The previously reported seven TAP2 haplotypes (A, B, C, D, E, F, and G) were observed; however haplotype H (Ile379-Thr565-Arg651-Ala665), reported by Tacheuchi et al. (17) was not found in this study. A new haplotype (Val379-Thr565-Arg651-Ala665) was observed in one person (controls), and we named it as haplotype I (Table 2). By combining the eight TAP2 haplotypes, 18 genotypes could be possible from AA to FG. However, their distributions were not different between the AR and control group (Table 6).
###end p 28
###begin title 29
DISCUSSION
###end title 29
###begin p 30
###xml 307 309 307 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 414 415 414 415 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 612 613 612 613 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 784 785 781 782 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">+</sup>
###xml 808 809 805 806 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
It is well known that the major histocompatibility complex (MHC) class I and II have fundamentally different antigen processing pathways. The exogenous antigens such as bacteria are degraded into antigenic peptides within the lysosomes. Upon fusion with endosomes, these peptides may bind MHC II molecules (18). Finally, peptide-loaded MHC class II molecules are delivered to the cell surface, and presented to CD4+ helper T cells. However, the endogenous antigens such as virus and tumor antigens are degraded within the proteasomes and actively transported across the endoplasmic reticulum membrane by TAP (8, 9). These peptides are then assembled with the MHC class I heavy chain and beta2-microglobulin. This complex is expressed on the cell surface, where it is recognized by CD8+ T cells. Suto et al. (7) suggested, however, that exogenous antigens can be channeled into the endogenous pathway where antigen presentation is mediated by MHC class I molecules. Therefore, TAP might participate in both endogenous and exogenous antigen processing.
###end p 30
###begin p 31
###xml 327 328 327 328 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 372 376 372 376 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 381 385 381 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 462 463 462 463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 465 466 465 466 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 473 477 473 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 533 537 533 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
Because AR is a disease caused by inhalant exogenous antigens such as pollens and house dust mites, the preferential pathway of antigen processing is known to be MHC class II. However, it would be possible that inhalant antigenic peptides can be routed into the MHC class I (endogenous) pathway, involving TAP molecules in AR (2). The genes encoding the two TAP subunits (TAP1 and TAP2) are located within the MHC class II region between the DPB1 and DQB1 loci (8, 9). Two TAP1 dimorphic sites (Ile/Val-333 and Asp/Gly-637) and five TAP2 dimorphic sites (Val/Ile-379, Ala/Thr-565, Arg/Cys-651, Thr/Ala-665 and Stop/Gln-687) have been widely investigated. It is possible that these genetic variations may modify the TAP molecular structures, influencing antigen peptide selection.
###end p 31
###begin p 32
###xml 191 193 191 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 194 196 194 196 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B21">21</xref>
###xml 283 284 283 284 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 336 340 336 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 408 410 408 410 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 444 448 444 448 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 673 677 673 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 700 704 700 704 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 734 738 734 738 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 738 741 738 741 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">333</sup>
###xml 754 758 754 758 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 758 761 758 761 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">637</sup>
###xml 767 771 767 771 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 1031 1035 1031 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 1147 1148 1147 1148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1164 1166 1164 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1178 1182 1178 1182 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 1245 1249 1245 1249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 1292 1293 1292 1293 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 1314 1316 1314 1316 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 1342 1346 1342 1346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 181 189 <span type="species:ncbi:9606">patients</span>
###xml 1775 1783 <span type="species:ncbi:9606">patients</span>
TAP gene polymorphisms have been investigated in several MHC-associated diseases (multiple sclerosis, Grave's disease, and insulin-dependent diabetes mellitus), mostly in Caucasian patients (19-21). Until now, there have been few studies on AR in an Asian population. Ismail et al. (2) provided evidence of a strong association between TAP1 polymorphism and atopy in a Tunisian population. Tacheuchi et al. (12) reported no association between TAP1 gene polymorphism and AR in a Japanese population. Therefore, we believe that it is one of the controversial issues in the pathogenetic mechanism of the AR. In this study, we demonstrated a strong association between AR and TAP1 polymorphism, but not TAP2. In the AR group, Ile/Val at TAP1333, Asp/Gly at TAP1637, and TAP1 haplotypes C and D were significantly decreased when compared to controls. These results are different from those of previous studies. To find any causes of such discrepancy, we compared the results of controls in different ethnics. In our study, a decreased TAP1 haplotype A frequency and increased haplotype C and D frequencies were observed when compared to the Tunisian (2) and Japanese (12) controls. TAP1 haplotype D also deserves to be mentioned. In control groups, TAP1 haplotype D was found in 5% of Tunisians (2), 7.3% of Japanese (12). However, in our study, TAP1 haplotype D was found in 11.7% of controls. There might be the various spectrums of genetic pools among different ethnic groups, and therefore, it may be not meaningful to simply compare the results of genetic polymorphisms that have been done in different ethnic groups. Other possible reasons for such discrepancies might be due to multiple factors such as different phenotypic characteristics, heterogeneity within groups of patients and controls, and different genotyping methods.
###end p 32
###begin p 33
###xml 58 62 58 62 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
In this study, we also analyzed the relationships between TAP1 gene polymorphisms and the results of allergy tests such as total serum IgE, and the strength and the multiplicity of positive allergens in skin prick tests; however, there was no association between them (data not shown).
###end p 33
###begin p 34
###xml 75 79 75 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 102 106 102 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 142 146 142 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
In conclusion, this study showed a meaningful association between AR and a TAP1 polymorphism, but not TAP2. Therefore, it is suggested that a TAP1 gene polymorphism may be an important factor in AR pathogenesis in a Korean population.
###end p 34
###begin p 35
###xml 48 66 48 66 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Hanyang University</funding-source>
###xml 78 87 78 87 <award-id xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">HY-2002-I</award-id>
This work was supported by the research fund of Hanyang University (Grant No. HY-2002-I).
###end p 35
###begin article-title 36
Association of atopic dermatitis to the beta subunit of the high affinity immunoglobulin E receptor
###end article-title 36
###begin article-title 37
Polymorphism in transporter antigen peptides gene (TAP1) associated with atopy in Tunisians
###end article-title 37
###begin article-title 38
Single nucleotide polymorphism and linkage disequilibrium within the TCR alpha/delta locus
###end article-title 38
###begin article-title 39
STAT6 gene polymorphisms in allergic rhinitis
###end article-title 39
###begin article-title 40
Analysis of the variations in IL-28RA gene and their association with allergic rhinitis
###end article-title 40
###begin article-title 41
Antigen presentation
###end article-title 41
###begin article-title 42
A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptides
###end article-title 42
###begin article-title 43
MHC class II region encoding proteins related to the multidrug resistance family of transmembrane transporters
###end article-title 43
###begin article-title 44
Sequences encoded in the class II region of the MHC related to the "ABC" superfamily of transporters
###end article-title 44
###begin article-title 45
###xml 50 58 <span type="species:ncbi:9606">patients</span>
Association of TAP2 gene polymorphisms in Chinese patients with rheumatoid arthritis
###end article-title 45
###begin article-title 46
###xml 63 71 <span type="species:ncbi:9606">patients</span>
TAP1 and TAP2 polymorphisms analysis in northwestern Colombian patients with systemic lupus erythematosus
###end article-title 46
###begin article-title 47
Lack of association between gene polymorphism of transporters associated with antigen processing and allergic rhinitis in a Japanese population
###end article-title 47
###begin article-title 48
TAP1 and TAP2 gene polymorphism in rheumatoid arthritis in a population in eastern France
###end article-title 48
###begin article-title 49
Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)
###end article-title 49
###begin article-title 50
Alleles and haplotypes of the MHC-encoded ABC transporters TAP1 and TAP2
###end article-title 50
###begin article-title 51
TAP2 association with insulin-dependent diabetes mellitus is secondary to HLA-DQB1
###end article-title 51
###begin article-title 52
Association of TAP1 and TAP2 with systemic sclerosis in Japanese
###end article-title 52
###begin article-title 53
Invariant chain structure and MHC class II function
###end article-title 53
###begin article-title 54
MHC-encoded TAP1 and TAP2 dimorphisms in multiple sclerosis
###end article-title 54
###begin article-title 55
Polymorphisms of TAP1 and TAP2 genes in Grave's disease
###end article-title 55
###begin article-title 56
Major histocompatibility complex-encoded antigen processing gene polymorphism in IDDM
###end article-title 56
###begin p 57
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
TAP1 codon 333 genotyping by ARMS-PCR. Four oligonucleotides were included in each polymerase chain reaction mix. Lanes 4, 6, 7, 8 and 11 consist of one control and one allele-specific 241 bp fragment defining the Ile/Ile homozygote. Lanes 1, 2, 3, 9 and 10 consist of one control and two allele-specific, smaller fragments (241 bp and 351 bp) defining the Ile/Val heterozygote. Lane 5 consists of one control and one allele-specific 351 bp fragment defining the Val/Val homozygote.
###end p 57
###begin p 58
###xml 42 46 42 46 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 51 55 51 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
Oligonucleotide primers used for ARMS-PCR TAP1 and TAP2 typing
###end p 58
###begin p 59
ARMS-PCR, amplification refractory mutation system-polymerase chain reaction.
###end p 59
###begin p 60
###xml 16 20 16 20 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
Nomenclature of TAP1 and TAP2 haplotypes
###end p 60
###begin p 61
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
TAP1 polymorphisms in allergic rhinitis patients and controls
###end p 61
###begin p 62
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*, 95% confidence interval.
###end p 62
###begin p 63
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP1</italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
TAP1 haplotypes in allergic rhinitis patients and controls
###end p 63
###begin p 64
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*, 95% confidence interval.
###end p 64
###begin p 65
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 40 48 <span type="species:ncbi:9606">patients</span>
TAP2 polymorphisms in allergic rhinitis patients and controls
###end p 65
###begin p 66
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*, 95% confidence interval.
###end p 66
###begin p 67
###xml 0 4 0 4 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">TAP2</italic>
###xml 37 45 <span type="species:ncbi:9606">patients</span>
TAP2 haplotypes in allergic rhinitis patients and controls
###end p 67
###begin p 68
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">*</sup>
*, 95% confidence interval.
###end p 68

